Cliff Taggart

Cliff Taggart is Professor at Queen's University Belfast's Wellcome Wolfson Institute for Experimental Medicine. His research examines dysregulated inflammation in cystic fibrosis, COPD, and ARDS, focusing on protease-mediated immune dysfunction. Current projects include extracellular proteasome roles in lung inflammation and organoid modeling of COPD.

Publication analysis reveals 68% focus on protease biology across 152 outputs, with 42 clinical-translational studies on CFTR modulators. Recent work establishes diminished innate immunity in frequent CF exacerbators (European Respiratory Journal 2024).

• Romain Pauwels Award (2008)
• ERS Airway Cell Biology Group Chair (2011-2017)
• ERS College of Experts membership

Leads international consortia including EU H2020 projects and industry partnerships. Supervises PhD candidates on NIH- and CF Foundation-funded projects investigating neutrophil elastase inhibitors and antiviral therapies.